Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. - Wikidata - awgldk - TriplyDB

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

http://www.wikidata.org/entity/Q36938343

about

Perspectives on menopause and women with HIV Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review HIV infection and osteoporosis HIV infection and older Americans: the public health perspective Menopause-associated metabolic manifestations and symptomatology in HIV infection: a brief review with research implications Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach Management of endocrine disease: Secondary osteoporosis: pathophysiology and management HIV: inflammation and bone A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine Bone health in HIV and hepatitis B or C infections Assessment and management of musculoskeletal disorders among patients living with HIV.Ageing and inflammation in patients with HIV infection.HIV infection and bone disease.Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United States Short-term bone loss in HIV-infected premenopausal women Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence Incident fractures in HIV-infected individuals: a systematic review and meta-analysis Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis.The effect of HIV infection on the incidence and severity of circular external fixator pin track sepsis: a retrospective comparative study of 229 patients.Residual immune dysregulation syndrome in treated HIV infection.Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.Th17, gut, and HIV: therapeutic implications Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.Bone mineral density in children and adolescents with perinatal HIV infection HIV infection, inflammation, immunosenescence, and aging.Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapy.Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan.Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection Bones, Fractures, Antiretroviral Therapy and HIV.

P2860

Q26772852-FEC84864-5E08-4E8C-8494-4529E207C981 Q26798289-E0F3BED9-7425-4C6B-9416-ABE1151DE863 Q26853139-FF594185-65F3-44F4-8160-CF517FF0A0B2 Q26858824-B5EF7F22-FE62-49BF-8A57-4595C5C229D1 Q26865187-E70E1AE4-9635-4314-A909-39E81184967F Q26866452-C92FD7E1-21C7-43E4-B3FF-27CF65D411EB Q26998249-A0A2BF29-C395-405B-BD70-AC5F3EBC40CA Q27010898-74D13D12-FE24-414E-BBBB-E1D23827AC2D Q28534700-07B6B74C-FE6C-484A-ADB1-E2A7D96636B6 Q28728374-4BEAEF8F-6276-487B-A1E6-393738FAA727 Q30238946-8D00BDFF-E85E-420D-9544-68270CB7D8E1 Q30239955-D10E7E56-7E5D-419D-9D14-D699C1A91305 Q30244296-AFC266B7-FAAB-4275-BEB8-7AE2E0428E3F Q30249771-527E09F7-7610-42FC-8065-0E1BEE6A4256 Q31124706-6DEDE93A-80CA-4EEC-AE7E-237021FE0B26 Q33590784-3E4E6F41-0A6F-469B-A963-6191F2C5DB12 Q33618567-0FB699DC-9BA8-498E-AD94-927C6837901B Q33627227-EDFA64B8-6D03-46CC-814F-8393E7FB2CB5 Q33648297-BB5260C1-5831-4F6E-9880-EEE6BB3D1529 Q33722412-7F9C627E-B706-4F4A-9296-D4F96FF62DB6 Q33723186-42015B9E-EA4E-42ED-87FF-506260A240CA Q33736156-4FA66D9C-502A-45C9-9B97-55870AFD0F9C Q33832012-FA61159D-4028-4308-9826-36F3269CDD19 Q33916243-87104426-C5DA-4750-B345-D1E07EF1CA47 Q34006228-63F797BE-D966-4547-B594-F937DE2CCB8A Q34020121-B2FEE7E3-C0CA-413A-90CC-B26D55AC08E0 Q34024085-B7F82969-EDA4-43A4-B598-6A1E73A53706 Q34050602-48ABD1F0-F73D-4A45-A9C8-89FEB8C92198 Q34068440-CA81FF2B-D5C7-4B1A-AD70-9A7AAEB758D7 Q34116648-C0F153FE-9BE3-4343-9418-FB8ED4F848E4 Q34150394-AFFF1FFD-22C6-4EEF-BCCF-FEE2024CED86 Q34150710-30C3063D-0145-4D32-AFC8-68AAB074E623 Q34168353-EACFCF2E-5FD9-405F-9628-3B0CB9BBEC1F Q34213832-5030523D-8BDF-4451-AC78-ADF093A1E233 Q34264297-0C22BBD5-E678-4C8E-B27B-082A37CFC909 Q34274127-58B6AE8B-D249-4B2F-97B9-EF6FE88CDFF3 Q34441071-DDAF800C-7551-4B00-9AAA-67B6A75214B6 Q34478840-7B0C6410-4B80-4B36-AFD8-9BF19CC7BD2A Q34506677-C073284F-698D-4B56-9D55-36372309CF9D Q34556859-02F903FC-B5D4-40DC-AEDB-5ECAA46C638E

P2860

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

http://www.wikidata.org/entity/Q36938343

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Fracture prevalence among huma ...... large U.S. healthcare system.

@en

type

label

Fracture prevalence among huma ...... large U.S. healthcare system.

@en

prefLabel

Fracture prevalence among huma ...... large U.S. healthcare system.

@en

P1433

Q36938343-F94A86F0-6DA4-47C8-A0A3-253AE90EDEA6

P1476

Q36938343-860BDF6D-59C6-4CF3-9FFB-0BC272CB5663

P2093

Q36938343-093F1298-6693-46BF-AC80-545FA303A2A2

Q36938343-24028EE6-B8D5-474C-B0D5-7652C16BA166

Q36938343-9E438E14-3006-4D93-9C9D-3C0601C0553F

Q36938343-9EF82396-2200-4F55-9A99-2AF3FC617820

P2860

Q36938343-19483E5D-3459-4974-9F6C-DC509A62D74C

Q36938343-1A496B71-9F31-4BBA-8468-6DA2D20D2A61

Q36938343-1B872E73-F9FE-4912-AC30-C48A4ECF2B3F

Q36938343-1DFDA349-D2E7-4EEB-BA4E-544A27382A78

Q36938343-1F1DA333-EF8D-4953-A8FA-650A2B3D297A

Q36938343-2A2E02D6-614F-4F4B-A93E-32C545BCA201

Q36938343-2D3EED9B-82BF-4F65-ADE6-135019FDDDC6

Q36938343-34E144D8-0906-4B66-ABB4-D07BF2C0C991

Q36938343-5C0103CC-5AF8-439A-93D2-9C2AA13B98D7

Q36938343-65B22447-D1C8-42D6-8457-3C91563FF684

P304

Q36938343-18AE0327-0CC4-4E18-BC55-33CA7D804483

P31

Q36938343-4128BE2B-7E93-4107-BFEA-35769C9B28DF

P356

Q36938343-3381952A-4DCB-4D8D-878B-9D976FE40606

P407

Q36938343-252B16B5-4C39-4AE6-8968-C09AEEA3BFC1

P433

Q36938343-5F273D2F-E8C5-4A6E-BB9B-2A2B2C7A30EE

P478

Q36938343-5A32F65F-79CB-45F3-A1CD-D0608B1D5DD3

P577

Q36938343-4AE3F073-5ED8-47C3-86CA-D55C2B3AF752

P5875

Q36938343-1AF35EC8-8246-47B9-98B2-CC09ACA57CF9

P698

Q36938343-CC2812B3-3DB7-4A31-9BDA-CA361BC8C9BA

P932

Q36938343-AC7F1515-9283-46A9-902A-82928DB8A04A

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Fracture prevalence among huma ...... large U.S. healthcare system.

@en

P2093

Hang Lee

http://www.w3.org/2001/XMLSchema#string

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

Todd T Brown

http://www.w3.org/2001/XMLSchema#string

Virginia A Triant

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.

Long-term risk of incident vertebral fractures.

Bone mass and mineral metabolism in HIV+ postmenopausal women.

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection

Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.

Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS).

Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy.

P304

3499-3504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-0828

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5259212

http://www.w3.org/2001/XMLSchema#string

P698

18593764

http://www.w3.org/2001/XMLSchema#string

P932

2567857

http://www.w3.org/2001/XMLSchema#string